Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue renin angiotensin systems.

Richard N Re1

  • 1Research Division, Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA. rre@ochsner.org

The Medical Clinics of North America
|February 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Look Back at the Second Generation of Ochsner Research.

Ochsner journal·2024
Same author

Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.

JAMA cardiology·2023
Same author

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.

The New England journal of medicine·2021
Same author

Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial.

JAMA cardiology·2020
Same author

Edward D. Frohlich, MD: September 10, 1931-August 16, 2019.

Hypertension (Dallas, Tex. : 1979)·2019
Same author

Association of Post-Traumatic Stress Disorder Symptoms Following Hurricane Katrina With Incident Cardiovascular Disease Events Among Older Adults With Hypertension.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2018
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

The Renin-Angiotensin-Aldosterone System (RAAS) regulates blood pressure and fluid balance. Its diverse roles extend to immunity and tissue health, with local tissue systems offering new therapeutic targets.

Area of Science:

  • Physiology
  • Endocrinology
  • Cardiovascular Biology

Background:

  • The Renin-Angiotensin-Aldosterone System (RAAS) is a key regulator of vascular tone and intravascular volume.
  • Emerging evidence highlights angiotensin II's role in immunomodulation, atherosclerosis, and plaque rupture.
  • The RAAS operates both systemically and in multiple tissue-specific contexts.

Purpose of the Study:

  • To review the multifaceted physiological and pathophysiological roles of the RAAS.
  • To emphasize the significance of tissue-specific RAAS components and their regulation.
  • To explore the therapeutic implications of targeting local RAAS activities.

Main Methods:

  • Literature review and synthesis of current research on RAAS biology.
  • Analysis of the regulatory mechanisms of RAAS components at various levels.

Related Experiment Videos

  • Examination of the impact of systemic and local RAAS on physiological functions and disease.
  • Main Results:

    • Angiotensin II exhibits wide-ranging effects, including immunomodulation, fat cell differentiation, and neuromodulation.
    • Tissue-specific RAAS can operate independently of the circulating system, with unique regulatory controls.
    • Local RAAS components and their concentrations can vary significantly between tissues.

    Conclusions:

    • The RAAS is involved in numerous physiological and pathophysiological processes beyond its classical roles.
    • Interruption of local RAAS pathways, in addition to systemic ones, is a promising therapeutic strategy.
    • Further understanding of tissue-specific RAAS biology will likely yield novel therapeutic interventions.